Additionally, the 36-month beta value for CNTG is -0.65. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for CNTG is 11.98M and currently, short sellers hold a 0.05% ratio of that float. The average trading volume of CNTG on May 08, 2024 was 69.76K shares.
CNTG) stock’s latest price update
Centogene NV (NASDAQ: CNTG)’s stock price has gone decline by -10.49 in comparison to its previous close of 0.45, however, the company has experienced a -8.45% decrease in its stock price over the last five trading days. Market Watch reported 2023-09-01 that Shares of Centogene NV CNTG, +8.31% gained 7% premarket on Friday after the company announced data confirming the utility of its proprietary biomarker lyso-Gb1 in indicating the severity of Gaucher disease, a rare inherited disorder that affects the body’s ability to break down a certain type of fat. The study results also indicate that lyso-Gb1 could help predict the clinical course of patients and personalize care for the disease, Centogene said in a release.
CNTG’s Market Performance
Centogene NV (CNTG) has seen a -8.45% fall in stock performance for the week, with a -38.14% decline in the past month and a -63.92% plunge in the past quarter. The volatility ratio for the week is 9.76%, and the volatility levels for the past 30 days are at 11.31% for CNTG. The simple moving average for the last 20 days is -16.18% for CNTG’s stock, with a simple moving average of -59.29% for the last 200 days.
Analysts’ Opinion of CNTG
Many brokerage firms have already submitted their reports for CNTG stocks, with Credit Suisse repeating the rating for CNTG by listing it as a “Outperform.” The predicted price for CNTG in the upcoming period, according to Credit Suisse is $14 based on the research report published on August 05, 2021 of the previous year 2021.
Evercore ISI, on the other hand, stated in their research note that they expect to see CNTG reach a price target of $21. The rating they have provided for CNTG stocks is “In-line” according to the report published on April 24th, 2020.
CNTG Trading at -33.95% from the 50-Day Moving Average
After a stumble in the market that brought CNTG to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -79.66% of loss for the given period.
Volatility was left at 11.31%, however, over the last 30 days, the volatility rate increased by 9.76%, as shares sank -27.12% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -45.43% lower at present.
During the last 5 trading sessions, CNTG fell by -4.50%, which changed the moving average for the period of 200-days by -63.78% in comparison to the 20-day moving average, which settled at $0.4727. In addition, Centogene NV saw -66.43% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CNTG
Current profitability levels for the company are sitting at:
- -0.76 for the present operating margin
- 0.39 for the gross margin
The net margin for Centogene NV stands at -0.86.
When we switch over and look at the enterprise to sales, we see a ratio of 0.27. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.45.
Conclusion
In conclusion, Centogene NV (CNTG) has seen bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high..
